Back

Safety, feasibility and performance of Valvosoft non-invasive ultrasound therapy in patients with severe symptomatic calcific aortic valve stenosis. First-in-Man

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: New Insights into Percutaneous Treatments of Valvular Disease Intervention ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor Emmanuel Messas

European Hospital Georges Pompidou, Paris (France)

6 More presentations in this session

Presentation thumbnail
Association between prosthesis geometry and leaflet thrombosis following transcatheter aortic valve replacement
Doctor H. Rashid (Melbourne, AU)
Abstract Slides
Presentation thumbnail
Temporal trends in readmissions after transcatheter aortic valve replacement
Mr M. Hendrickson (Chapel Hill, US)
Abstract Slides
Presentation thumbnail
Age-related clinical and hemodynamic outcome following transcatheter aortic valve replacement: a swiss TAVI registry analysis.
Doctor A. Attinger (Fribourg, CH)
Abstract Slides
Presentation thumbnail
Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis
Mr D. Ueshima (Chiba, JP)
Abstract Slides
Presentation thumbnail
Six-month and one-year outcomes with the PASCAL transcatheter valve repair system for patients with mitral regurgitation from the multicentre, prospective CLASP study
Doctor K. Spargias (Athens, GR)
Abstract Slides

Access the full session

Session thumbnail
New Insights into Percutaneous Treatments of Valvular Disease

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources